ASSET PURCHASE AGREEMENT BY AND BETWEEN Novartis Pharma AG AND Stratatech CorporationAsset Purchase Agreement • June 30th, 2022 • Mallinckrodt PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2022 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2022 (the “Effective Date”), by and between Novartis Pharma AG, an entity organized under the laws of Switzerland (“Buyer”), and Stratatech Corporation, a corporation organized under the laws of Delaware (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.